Close Menu
Timesbite

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Vinfast Inaugurates Electric Vehicle Assembly Plant in Tamil Nadu, India

    August 4, 2025

    Coffee Table Book ‘Threaded Tales of Vidarbha’ Launched to Celebrate Region’s Textile Heritage

    August 4, 2025

    Signify and BharatCares Partners to Illuminate 58 Gram Panchayats in Ayodhya, Uttar Pradesh, Benefiting over 2.4 Lakh People Under Har Gaon Roshan CSR initiative

    August 4, 2025
    Facebook X (Twitter) Instagram
    TimesbiteTimesbite
    Demo
    • Home
    • Latest
    • Business
    • Interviews
    • Lifestyle
    • Hervoice/TBTV
    • Sports
    Timesbite
    Home » Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month
    Business

    Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

    Metropolis Healthcare reveals groundbreaking findings from its molecular genomics study, underscoring the importance of lung cancer awareness and early detection.
    EditorBy EditorNovember 22, 2024Updated:November 23, 2024No Comments5 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements in early detection and new treatment options, particularly genetic profiling, are improving survival rates. These innovations are part of precision oncology, a rapidly growing field that customizes treatments based on a patient’s unique genetic makeup, enabling personalized care.

    Molecular Genomics Study highlights the role of Next-Generation Sequencing (NGS) in lung cancer treatment

    In observance of Lung Cancer Awareness Month this November, Metropolis Healthcare, one of India’s leading and most reputed diagnostic chains, conducted a landmark seven-year research study (2015-2021) to examine the clinicopathological features and molecular changes in lung cancer patients. The study analyzed data from over 3,200 individuals diagnosed with lung cancer, focusing on genetic alterations in key genes such as Epidermal Growth Factor Receptor (EGFR), Anaplastic Lymphoma Kinase (ALK), and c-ros oncogene 1 (ROS1). These genes play a pivotal role in the development of non-small cell lung cancer (NSCLC). Molecular markers like these are essential for guiding targeted therapies, which are revolutionizing lung cancer care by tailoring treatment to each patient’s genetic profile.

    Key Findings of the Study:

    More than 3,200 lung cancer tissue samples were analyzed, with 83% diagnosed as adenocarcinoma (a common type of NSCLC) and 17% as squamous cell carcinoma (a subtype affecting the lung’s airways). Both types were most common in patients over 60 years.

    Genomic Alterations: The most common genetic alterations found were:

    EGFR mutations (29.1%) – Mutations in the Epidermal Growth Factor Receptor (EGFR) gene, which are common in lung cancer and make the patient a candidate for targeted treatment.

    ALK rearrangements (7.8%) – Changes in the Anaplastic Lymphoma Kinase (ALK) gene are also a target for treatment.

    ROS1 rearrangements (3.5%) – Alterations in the ROS1 gene, which, like ALK, can also fuel cancer progression & are amenable to targeted therapy.

    EGFR Mutation Locations: EGFR mutations were most commonly found in exon 19 (65.6%) and exon 21 (32.1%). These are specific regions of the EGFR gene where changes can affect its function, often leading to uncontrolled cell growth.

    Higher rates of EGFR mutations were observed in younger patients, and they were more frequent in female patients.

    ALK positivity was more frequently detected in younger patients, with a balanced gender distribution.

    Impact:

    Molecular markers like EGFR mutations, ALK, and ROS1 rearrangements are key targets for treatment in NSCLC, with approved drugs available for these alterations.

    Next-generation sequencing (NGS) helps identify more lung cancer cases and uncover additional molecular targets, leading to more treatment options.

    Commenting on the study, Dr. Kirti Chadha, Chief Scientific and Innovation Officer & Senior Oncopathologist, Metropolis Healthcare, said, “Studying genetic mutations and alterations in cancer-related genes is essential for guiding clinicians in selecting the most suitable treatment-whether it involves surgery, medications, or chemotherapy. This detailed molecular analysis forms the foundation of personalized and precision medicine, allowing doctors to adjust therapies based on a patient’s unique genetic profile and likely response. By tailoring treatments in this way, clinicians can significantly improve the effectiveness of NSCLC cancer care, offering patients treatment approaches best aligned with their individual needs.“

    The study underscores the importance of molecular profiling in NSCLC, as identifying these genetic alterations can guide targeted therapy, potentially improving patient outcomes. Advances in molecular diagnostics, particularly Next Generation Sequencing (NGS), have revolutionized the field of oncology. NGS allows for the simultaneous sequencing of multiple genes, providing comprehensive insights into the genetic makeup of tumors. This technology enables the identification of actionable mutations, helping oncologists tailor treatments to individual patients.

    The 2017 NCCN guidelines highlighted the importance of genetic profiling in NSCLC, focusing on key mutations in ALK, ROS1, and EGFR. Building on this, the 2023 ESMO guidelines for metastatic NSCLC emphasized a broader set of biomarkers, including BRAF, RET, MET, NTRK, HER2, and KRAS G12C, using advanced DNA and RNA panels. This underscores the critical role of molecular diagnostics in decoding lung cancers genetic landscape to enable personalized treatment strategies. Metropolis Healthcare remains committed to advancing this research by expanding mutation detection capabilities through comprehensive 50-gene panels in alignment with evolving global standards.

    About Metropolis Healthcare Limited

    Established in 1981, Metropolis Healthcare Limited is the leading diagnostics company in India, with a widespread presence in 22 states, 3 Union Territories and over 700 towns. Metropolis touches millions of lives each year by providing actionable health insights to patients and doctors. Metropolis offers a comprehensive range of more than 4,000 plus tests and profiles, including advanced tests for the diagnosis of cancer, neurological disorders, infectious diseases, and various genetic abnormalities. The company is empowered with a robust network of 202 labs, 4,336 service centers and over 10,000 touch points. Metropolis’ commitment to quality and accuracy in each test is reinforced by its consistent CAP proficiency score of more than 98% over the past decade, placing it among the top 1% laboratories worldwide for quality assurance. The Metropolis philosophy rests on the pillars of technological superiority, a warm, patient centric approach and reliable diagnostic reports.

    For more information, please visit www.metropolisindia.com or click on Twitter, Facebook, or LinkedIn

    cancer findings cancer research genomics study healthcare innovation lung cancer awareness Lung Cancer Awareness Month lung cancer detection lung cancer study Metropolis Healthcare molecular genomics
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Editor
    • Website

    Related Posts

    Vinfast Inaugurates Electric Vehicle Assembly Plant in Tamil Nadu, India

    August 4, 2025

    Coffee Table Book ‘Threaded Tales of Vidarbha’ Launched to Celebrate Region’s Textile Heritage

    August 4, 2025

    Signify and BharatCares Partners to Illuminate 58 Gram Panchayats in Ayodhya, Uttar Pradesh, Benefiting over 2.4 Lakh People Under Har Gaon Roshan CSR initiative

    August 4, 2025

    VANAHA Collaborates with Aston Martin New Delhi for an Exclusive Luxury Showcase in Pune

    August 4, 2025

    Zigly’s ‘International Happy Pets Day’ Celebrates Pet Friendship and Brings Pet Community Together for Social Cause

    August 4, 2025

    Over 130 Indian MLAs & MLCs from 24 States, 21 Parties to Attend Global NCSL Summit in Boston, Facilitated by NLC Bharat 2025

    August 4, 2025
    Leave A Reply Cancel Reply

    Top Posts

    Top 5 Businessmen in India: Titans of Industry

    September 24, 2024

    OPPO Find X8 Series Goes on Sale: Price, Launch Offers, Specs and More

    December 4, 2024

    Baba Siddique Assassinated: Mumbai Ex-Minister Gunned Down on Dussehra Night

    October 12, 2024

    Top 5 Online Businesses to Watch for in 2025

    September 23, 2024
    Don't Miss
    Business

    Vinfast Inaugurates Electric Vehicle Assembly Plant in Tamil Nadu, India

    By EditorAugust 4, 2025

    VinFast today officially inaugurated its electric vehicle (EV) assembly plant at the SIPCOT Industrial Park…

    Coffee Table Book ‘Threaded Tales of Vidarbha’ Launched to Celebrate Region’s Textile Heritage

    August 4, 2025

    Signify and BharatCares Partners to Illuminate 58 Gram Panchayats in Ayodhya, Uttar Pradesh, Benefiting over 2.4 Lakh People Under Har Gaon Roshan CSR initiative

    August 4, 2025

    VANAHA Collaborates with Aston Martin New Delhi for an Exclusive Luxury Showcase in Pune

    August 4, 2025
    Editors Picks

    What is a Credit Score? The beginner guide for the first-time Indian borrower

    October 26, 2024

    Blending Traditional Classrooms with Augmented Reality: A Transformative Approach to Learning

    October 24, 2024

    Sony India Establishes ‘Cinema is Coming Home’ Concept for BRAVIA Televisions, Stamped by Acclaimed Filmmaker Mr. S.S. Rajamouli’s Cinematic Vision

    October 18, 2024

    Third Wave Coffee marks 8 years of creative journeys fueled by coffee with the ‘Inspiring Indian Crea8ors’ campaign

    October 18, 2024
    Latest Posts

    Subscribe to News

    Get the latest sports news from NewsSite about world, sports and politics.

    Advertisement
    Don't Miss
    Business

    Vinfast Inaugurates Electric Vehicle Assembly Plant in Tamil Nadu, India

    By EditorAugust 4, 2025

    VinFast today officially inaugurated its electric vehicle (EV) assembly plant at the SIPCOT Industrial Park…

    Coffee Table Book ‘Threaded Tales of Vidarbha’ Launched to Celebrate Region’s Textile Heritage

    August 4, 2025

    Signify and BharatCares Partners to Illuminate 58 Gram Panchayats in Ayodhya, Uttar Pradesh, Benefiting over 2.4 Lakh People Under Har Gaon Roshan CSR initiative

    August 4, 2025

    VANAHA Collaborates with Aston Martin New Delhi for an Exclusive Luxury Showcase in Pune

    August 4, 2025
    Our Picks

    Vinfast Inaugurates Electric Vehicle Assembly Plant in Tamil Nadu, India

    August 4, 2025

    Coffee Table Book ‘Threaded Tales of Vidarbha’ Launched to Celebrate Region’s Textile Heritage

    August 4, 2025

    Signify and BharatCares Partners to Illuminate 58 Gram Panchayats in Ayodhya, Uttar Pradesh, Benefiting over 2.4 Lakh People Under Har Gaon Roshan CSR initiative

    August 4, 2025

    VANAHA Collaborates with Aston Martin New Delhi for an Exclusive Luxury Showcase in Pune

    August 4, 2025
    About Us
    About Us

    Welcome to TimesBite, your premier destination for up-to-the-minute news and in-depth analysis across a wide array of topics. Founded with the mission to deliver accurate, reliable, and engaging news coverage, TimesBite is dedicated to keeping our readers informed about the events that shape our world. We're accepting new partnerships right now.

    Email Us: editor@timesbite.com

    Editor’s Pick

    Vinfast Inaugurates Electric Vehicle Assembly Plant in Tamil Nadu, India

    August 4, 2025

    Coffee Table Book ‘Threaded Tales of Vidarbha’ Launched to Celebrate Region’s Textile Heritage

    August 4, 2025

    Signify and BharatCares Partners to Illuminate 58 Gram Panchayats in Ayodhya, Uttar Pradesh, Benefiting over 2.4 Lakh People Under Har Gaon Roshan CSR initiative

    August 4, 2025
    Most Popular

    Top 5 Businessmen in India: Titans of Industry

    September 24, 2024

    OPPO Find X8 Series Goes on Sale: Price, Launch Offers, Specs and More

    December 4, 2024

    Baba Siddique Assassinated: Mumbai Ex-Minister Gunned Down on Dussehra Night

    October 12, 2024
    Facebook X (Twitter) Instagram LinkedIn
    • About US
    • Disclaimer/ Privacy Policy
    • Contact Us
    © 2025 Timesbite. All rights reserved.

    Type above and press Enter to search. Press Esc to cancel.